Literature DB >> 15840510

Kinetic studies of small molecule interactions with protein kinases using biosensor technology.

Helena Nordin1, Maria Jungnelius, Robert Karlsson, Olof P Karlsson.   

Abstract

Protein kinases are among the most commonly targeted groups of molecules in drug discovery today. Despite this, there are few examples of using surface plasmon resonance (SPR) for kinase inhibitor interaction studies, probably reflecting the need for better developed assays for these proteins. In this article, we present a general methodology that uses biosensor technology to study small molecule binding to eight different serine/threonine and tyrosine kinases. Mild immobilization conditions and a carefully composed assay buffer were identified as key success factors. The methodology package consists of direct binding studies of compounds to immobilized kinases, kinase activity assays to confirm inhibitory effects, detailed kinetic analyses of inhibitor binding, and competition assays with ATP for identification of competitive inhibitors. The kinetic assays resolve affinity into the rates of inhibitor binding and dissociation. Therefore, more detailed information on the relation between inhibitor structure and function is obtained. This might be of key importance for the development of effective kinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840510     DOI: 10.1016/j.ab.2005.02.027

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  Inhibition of high-mobility-group A2 protein binding to DNA by netropsin: a biosensor-surface plasmon resonance assay.

Authors:  Yi Miao; Tengjiao Cui; Fenfei Leng; W David Wilson
Journal:  Anal Biochem       Date:  2007-10-23       Impact factor: 3.365

2.  Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states.

Authors:  Irina Kufareva; Ruben Abagyan
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

3.  Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.

Authors:  Liwei Chen; Daniele Pernazza; Latanya M Scott; Harshani R Lawrence; Yuan Ren; Yunting Luo; Xin Wu; Shen-Shu Sung; Wayne C Guida; Said M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

4.  An arginine switch in the species B adenovirus knob determines high-affinity engagement of cellular receptor CD46.

Authors:  B David Persson; Steffen Müller; Dirk M Reiter; Benedikt B T Schmitt; Marko Marttila; Chris Vanessa Sumowski; Sabine Schweizer; Ulrike Scheu; Christian Ochsenfeld; Niklas Arnberg; Thilo Stehle
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

5.  Human structural proteome-wide characterization of Cyclosporine A targets.

Authors:  Gang Hu; Kui Wang; Jody Groenendyk; Khaled Barakat; Marcin J Mizianty; Jishou Ruan; Marek Michalak; Lukasz Kurgan
Journal:  Bioinformatics       Date:  2014-08-28       Impact factor: 6.937

6.  A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis.

Authors:  Shinya Ito; Koji Ogawa; Koh Takeuchi; Motoki Takagi; Masahito Yoshida; Takatsugu Hirokawa; Shoshiro Hirayama; Kazuo Shin-Ya; Ichio Shimada; Takayuki Doi; Naoki Goshima; Tohru Natsume; Kazuhiro Nagata
Journal:  J Biol Chem       Date:  2017-10-12       Impact factor: 5.157

7.  Surface plasmon resonance using the catalytic domain of soluble guanylate cyclase allows the detection of enzyme activators.

Authors:  Filipa Mota; Charles K Allerston; Kathryn Hampden-Smith; John Garthwaite; David L Selwood
Journal:  Bioorg Med Chem Lett       Date:  2014-01-13       Impact factor: 2.823

8.  Defining binding efficiency and specificity of auxins for SCF(TIR1/AFB)-Aux/IAA co-receptor complex formation.

Authors:  Sarah Lee; Shanthy Sundaram; Lynne Armitage; John P Evans; Tim Hawkes; Stefan Kepinski; Noel Ferro; Richard M Napier
Journal:  ACS Chem Biol       Date:  2013-12-23       Impact factor: 5.100

9.  Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.

Authors:  Seungil Han; Anil Mistry; Jeanne S Chang; David Cunningham; Matt Griffor; Peter C Bonnette; Hong Wang; Boris A Chrunyk; Gary E Aspnes; Daniel P Walker; Arthur D Brosius; Leonard Buckbinder
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

10.  Label-free microscale thermophoresis discriminates sites and affinity of protein-ligand binding.

Authors:  Susanne A I Seidel; Christoph J Wienken; Sandra Geissler; Moran Jerabek-Willemsen; Stefan Duhr; Alwin Reiter; Dirk Trauner; Dieter Braun; Philipp Baaske
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-24       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.